SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales. Viking's ...

A new study examining a large sample of privately insured patients with obesity found that use of drugs such as Ozempic and Wegovy as anti-obesity medications more than doubled from 2022 to 2023.

In the United States, where 12% of adults say that they have at some stage taken GLP-1 agonists for diabetes or weight loss ...

No, instead I have discovered the transformative power of weight loss jabs. I am 5 weeks into Mounjaro, the weekly injectable medication that contains Tirzepatide, an active ingredient that supresses ...

Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

Eli Lilly shares slid in premarket trading after the drugmaker reported disappointing quarterly results, with sales of its popular diabetes and anti-obesity drugs lower than expected. Lilly said inven ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...